Pubfacts - Scientific Publication Data
  • Categories
  • |
  • Journals
  • |
  • Authors
  • Login
  • Categories
  • Journals

Search Our Scientific Publications & Authors

Publications
  • Publications
  • Authors
find publications by category +
Translate page:

Randomized, controlled trial of two tranexamic acid dosing protocols in adult spinal deformity surgery.

Authors:
John C F Clohisy Lawrence G Lenke Mostafa H El Dafrawy Rachel C Wolfe Elfaridah Frazier Michael P Kelly

Spine Deform 2022 Jun 25. Epub 2022 Jun 25.

Rady Children's Hospital, University of California, 3020 Children's Way, San Diego, CA, 92123, USA.

Background: Tranexamic acid (TXA) is an anti-fibrinolytic effective in reducing blood loss in orthopedic surgery. The appropriate dosing protocol for adult spinal deformity (ASD) surgery is not known. The purpose of this study was to evaluate two TXA protocols [low dose (L): 10 mg/kg bolus, 1 mg/kg/hr infusion; high dose (H): 50 mg/kg, 5 mg/kg/hr] in complex ASD surgery.

Methods: Inclusion criteria were ASD reconstructions with minimum 10 fusion levels or planned 3-column osteotomy (3CO). Standard demographic and surgical data were collected. Intraoperative estimated blood loss (EBL) was calculated by suction canisters minus irrigation plus estimated blood lost in sponges, estimated to the nearest 50 mL. Serious adverse events (SAE) were defined a priori as: venothromboembolic event (VTE), cardiac arrhythmia, myocardial infarction, renal dysfunction, and seizure. All SAE were recorded. Simple t tests compared EBL between groups. Mean EBL by total blood volume (TBV), transfusion volume, complications related to TXA were secondary outcomes.

Results: Sixty-two patients were enrolled and 52 patients completed the study; 25 were randomized to H and 27 to L. Demographic and surgical variables were not different between the two groups. EBL was not different between groups (H: 1596 ± 933 cc, L: 2046 ± 1105 cc, p = 0.12, 95% CI: - 1022 to 122 cc). EBL as a percentage of TBV was lower for the high-dose group (H: 29.5 ± 14.8%, L: 42.5 ± 26.2%, p = 0.03). Intraoperative transfusion volume (H: 961 ± 505 cc, L: 1105 ± 808 cc, p = 0.5) and post-operative transfusion volume (H: 513 ± 305 cc, L: 524 ± 245 cc, p = 0.9) were not different. SAE related to TXA were not different (p = 0.7) and occurred in 2 (8%) H and 3 (11%) L. There was one seizure (H), 2 VTE, and 2 arrhythmias.

Conclusion: No differences in EBL, transfusion volume, nor SAE were observed between H and L dose TXA protocols. High dose was associated with decreased TBV loss (13%). Further prospective study, with pharmacologic analysis, is required to determine appropriate TXA dosage in ASD surgeries.

Level Of Evidence: Therapeutic Level II.

Trial Registration: The study was registered at Clinicaltrials.gov (NCT02053363) February 3, 2014.

Download full-text PDF

Source
http://dx.doi.org/10.1007/s43390-022-00539-zDOI Listing
June 2022

Publication Analysis

Top Keywords

transfusion volume
16
high dose
8
estimated blood
8
spinal deformity
8
adult spinal
8
txa protocols
8
demographic surgical
8
blood loss
8
tranexamic acid
8
ebl groups
8
groups ebl
8
txa
6
ebl
6
volume
5
tbv transfusion
4
transfusion
4
volume complications
4
complications txa
4
txa secondary
4
volume tbv
4

Keyword Occurance

Similar Publications

Seven years (2015-2021) of blood donor screening for HEV-RNA in France: lessons and perspectives.

Authors:
Syria Laperche Claude Maugard Sébastien Lhomme Sophie Lecam Céline Ricard Isabelle Dupont Pascale Richard Pierre Tiberghien Florence Abravanel Pascal Morel Jacques Izopet Pierre Gallian

Blood Transfus 2022 Jul 25. Epub 2022 Jul 25.

Etablissement Français du Sang, La Plaine St-Denis, France.

Background: The French health authorities are considering expanding the current selective HEV-RNA testing procedure to include all donations in order to further reduce transfusion-transmitted HEV infection. Data obtained from blood donors (BDs) tested for HEV-RNA between 2015 and 2021 were used to assess the most efficient nucleic acid testing (NAT) strategy.

Materials And Methods: Viral loads (VLs) and the plasma volume of blood components, as well as an HEV-RNA dose of 3. Read More

View Article and Full-Text PDF
July 2022
Similar Publications

Effects of tranexamic acid on coagulofibrinolytic markers during the early stage of severe trauma: A propensity score-matched analysis.

Authors:
Satoshi Gando Atsushi Shiraishi Takeshi Wada Kazuma Yamakawa Seitaro Fujishima Daizoh Saitoh Shigeki Kushimoto Hiroshi Ogura Toshikazu Abe Toshihiko Mayumi Junichi Sasaki Joji Kotani Naoshi Takeyama Ryosuke Tsuruta Kiyotsugu Takuma Shin-Ichiro Shiraishi Yasukazu Shiino Taka-Aki Nakada Kohji Okamoto Yuichiro Sakamoto Akiyoshi Hagiwara Satoshi Fujimi Yutaka Umemura Yasuhiro Otomo

Medicine (Baltimore) 2022 Aug;101(32):e29711

Trauma and Acute Critical Care Center, Medical Hospital, Tokyo Medical and Dental University, Japan.

Tranexamic acid (TXA) reduces the risk of bleeding trauma death without altering the need for blood transfusion. We examined the effects of TXA on coagulation and fibrinolysis dynamics and the volume of transfusion during the early stage of trauma. This subanalysis of a prospective multicenter study of severe trauma included 276 patients divided into propensity score-matched groups with and without TXA administration. Read More

View Article and Full-Text PDF
August 2022
Similar Publications

The Efficacy and Safety of Intravenous Iron in Geriatric Hip Fracture Surgeries: A Systematic Review and Meta-Analysis.

Authors:
Mu-Min Cao Jia-Yu Chi Yuan-Wei Zhang Ren-Wang Sheng Wang Gao Ya-Kuan Zhao Yun-Feng Rui

World J Surg 2022 Aug 10. Epub 2022 Aug 10.

Department of Orthopaedics, School of Medicine, Zhongda Hospital, Southeast University, No. 87 Ding Jia Qiao, Nanjing, 210009, Jiangsu, People's Republic of China.

Background: With the increasing evidence provided by recent high-quality studies, the intravenous iron appears to be a reliable therapy for blood administration in geriatric patients with hip fractures. Here, this systematic review and meta-analysis were aimed to assess the effectiveness and safety of intravenous iron in geriatric patients sustaining hip fractures.

Methods: Potential pertinent literatures evaluating the effects of intravenous iron in the geriatric patients undergoing hip fractures were identified from Web of Science, PubMed, Embase, and Scopus. Read More

View Article and Full-Text PDF
August 2022
Similar Publications

Effect of goal-directed haemodynamic therapy guided by non-invasive monitoring on perioperative complications in elderly hip fracture patients within an enhanced recovery pathway.

Authors:
Juan V Lorente Francesca Reguant Anna Arnau Marcelo Borderas Juan C Prieto Jordi Torrallardona Laura Carrasco Patricia Solano Isabel Pérez Carla Farré Ignacio Jiménez Javier Ripollés-Melchor Manuel I Monge Joan Bosch

Perioper Med (Lond) 2022 Aug 10;11(1):46. Epub 2022 Aug 10.

School of Medicine and Health Sciences, International University of Catalonia (UIC), Barcelona, Spain.

Background: Goal-directed haemodynamic therapy (GDHT) has been shown to reduce morbidity and mortality in high-risk surgical patients. However, there is little evidence of its efficacy in patients undergoing hip fracture surgery. This study aims to evaluate the effect of GDHT guided by non-invasive haemodynamic monitoring on perioperative complications in patients undergoing hip fracture surgery. Read More

View Article and Full-Text PDF
August 2022
Similar Publications

Meta-Analysis of the Efficacy and Safety of Tranexamic Acid in Spinal Surgery.

Authors:
Xianguo Bao Haitao Lu Zengxin Gao Zhanpo Wu Youmin Chen Yingjun Chen Qinghua Cheng

Comput Math Methods Med 2022 27;2022:9406497. Epub 2022 Jul 27.

Department of Spinal Surgery, Nanjing Lishui People's Hospital, Nanjing, Jiangsu Province, China.

Objective: The safety and effectiveness of topical tranexamic acid in spinal surgery has not yet been reached, and further research is needed to confirm it. This study is aimed at detecting the effectiveness and safety on the tranexamic acid in spinal surgery.

Methods: The Cochrane Library, PubMed, Embase, CNKI, and other databases were searched. Read More

View Article and Full-Text PDF
August 2022
Similar Publications
}
© 2022 PubFacts.
  • About PubFacts
  • Privacy Policy
  • Sitemap